CJC-1295 is a synthetic analog of Growth HormoneReleasing Hormone (GHRH) designed to enhance the release of growth hormone (GH) from the pituitary gland. It exists in two forms: CJC-1295 without DAC (Drug Affinity Complex) and CJC-1295 with DAC. The presence of DAC extends the half-life of the peptide, affecting its release and duration of action on GH secretion.
Mechanism of Action
CJC-1295 without DAC mimics the physiological action of GHRH, binding to the GHRH receptors on the pituitary gland to stimulate the release of GH. Its effects are more immediate but with a shorter duration of action, requiring more frequent dosing.
CJC-1295 with DAC utilizes the Drug Affinity Complex technology to extend the peptide’s half-life. This form continuously stimulates the GH release over an extended period, typically up to a week, mimicking the natural pulsatile release of GH without significantly altering its natural pattern.
Benefits and Uses
Both forms of CJC-1295 offer a range of benefits, including:
Improved Sleep Quality: Some users report better sleep patterns, which is crucial for recovery and overall health.
Strengthened Immune System: GH has been known to enhance the immune response.
CJC-1295 without DAC is often preferred for more controlled GH release patterns, while CJC-1295 with DAC is chosen for its convenience of less frequent dosing and sustained GH levels.
